openPR Logo
Press release

Lucintel Forecasts the Global Thyroid Cancer Diagnostic Market to Reach $7.6 billion by 2030

09-18-2025 01:43 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Lucintel

Thyroid Cancer Diagnostic Market

Thyroid Cancer Diagnostic Market

According to a market report by Lucintel, the future of the global thyroid cancer diagnostic market looks promising with opportunities in the hospital, associated lab, independent diagnostic laboratory, diagnostic imaging center, and cancer research institute markets. The global thyroid cancer diagnostic market is expected to reach an estimated $7.6 billion by 2030 from $5.5 billion in 2024, at a CAGR of 5.5% from 2024 to 2030. The major drivers for this market are increasing incidence of thyroid cancer, growing focus on real time diagnosis and treatment, and rising awareness towards thyroid cancer.
A more than 150-page report to understand trends, opportunity and forecast in thyroid cancer diagnostic market to 2030 by product type (instruments and consumables & accessories), test type (imaging test, biopsy, blood test, and others), end use (hospital, associated labs, independent diagnostic laboratories, diagnostic imaging centers, cancer research institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World).
Lucintel forecasts that imaging test will remain the largest segment due to the increasing demand of high resolution and real time image testing.
Within this market, hospitals will remain the largest segment over the forecast period due to growing inflow of cancer diagnosis patient in hospitals, increasing consumer awareness, and growing investments in healthcare infrastructure across the globe.
Download sample by clicking on thyroid cancer diagnostic market
North America will remain the largest region due to increasing prevalence of thyroid cancer, rising healthcare expenditure, and favorable government initiative in the US for awareness, diagnostic and treatment.
Abbott, Hoffmann-La Roche, Thermo Fisher Scientific, Siemens Healthcare, Bio-Rad Laboratories, General Electric, Koninklijke Philips, Toshiba Corporation, Agilent Technologies, Illumina are the major suppliers in the thyroid cancer diagnostic market.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at helpdesk@lucintel.com To get access of more than 1000 reports at fraction of cost visit Lucintel's Analytics Dashboard.
About Lucintel
At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. +1-972-636-5056
Explore Our Latest Publications
IO-Link Hardware Products Market
Law Enforcement Biometrics Market
Multimodal Biometrics Machine Market
Network Security Hardware Market
O-RAN Hardware Market

8951 Cypress Waters Blvd, Suite 160 Dallas, TX 75019, USA
Tel: +1-972-636-5056

Lucintel is the one of the world's most reputed market research report company which provides market intelligence services that free up your market research and strategic planning resources (time, money and people) and allows you to focus on your core business. We assist you in the utilization of the best market intelligence for greater business gains and we do it faster, better and cheaper. Lucintel offers unmatched data and report quality as compared to the other market research report companies with highest customer satisfaction.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Lucintel Forecasts the Global Thyroid Cancer Diagnostic Market to Reach $7.6 billion by 2030 here

News-ID: 4187481 • Views:

More Releases from Lucintel

Lucintel Forecasts the Global Uterine Cancer Diagnostics Market to reach $11.2 billion by 2030
Lucintel Forecasts the Global Uterine Cancer Diagnostics Market to reach $11.2 b …
According to a market report by Lucintel, the future of the global uterine cancer diagnostics market looks promising with opportunities in the hospital, diagnostic center, and cancer research center markets. The global uterine cancer diagnostics market is expected to reach an estimated $11.2 billion by 2030 with a CAGR of 9.0% from 2024 to 2030. The major drivers for this market are the increasing cases of uterine cancer, technological advancement
Lucintel Forecasts the Global Skin Cancer Diagnostics & Therapeutics Market to Reach $18.1 billion by 2030
Lucintel Forecasts the Global Skin Cancer Diagnostics & Therapeutics Market to R …
According to a market report by Lucintel, the future of the global skin cancer diagnostics & therapeutics market looks promising with opportunities in the diagnosis and therapeutic markets. The global skin cancer diagnostics & therapeutics market is expected to reach an estimated $18.1 billion by 2030 from $13.5 billion in 2024, at a CAGR of 5.0% from 2024 to 2030. The major drivers for this market are increasing government initiatives
ucintel Forecasts the Global Ovarian Cancer Diagnostics Market to Reach $2.3 billion by 2030
ucintel Forecasts the Global Ovarian Cancer Diagnostics Market to Reach $2.3 bil …
According to a market report by Lucintel, the future of the global ovarian cancer diagnostics market looks promising with opportunities in the cancer diagnostic center, hospital laboratory, and research institute markets. The global ovarian cancer diagnostics market is expected to reach an estimated $2.3 billion by 2030 from $1.5 billion in 2024, at a CAGR of 6.9% from 2024 to 2030. The major drivers for this market are growing prevalence
Lucintel Forecasts the Global Non-Invasive Cancer Diagnostic Market to reach $199.2 billion by 2030
Lucintel Forecasts the Global Non-Invasive Cancer Diagnostic Market to reach $19 …
According to a market report by Lucintel, the future of the global non-invasive cancer diagnostic market looks promising with opportunities in the solid tumors, blood cancer, lung cancer, and breast cancer markets. The global non-invasive cancer diagnostic market is expected to reach an estimated $199.2 billion by 2030 with a CAGR of 6.8% from 2024 to 2030. The major drivers for this market are the rising concerns of chronic cancer,

All 5 Releases


More Releases for Thyroid

Rising Incidences of Thyroid Disorders Fuel Growth In The Thyroid Function Test …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Thyroid Function Test Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The market size for thyroid function tests has witnessed substantial growth in the past few years. The market is projected to expand from $1.7 billion in 2024 to $1.81 billion in 2025, with an
Rising Incidences of Thyroid Disorders Fuel Growth In The Thyroid Function Test …
The Thyroid Function Test Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Thyroid Function Test Market Size During the Forecast Period? The thyroid function test market has grown significantly in recent years. It is expected to grow from $1.7 billion in 2024
Thyroid Function Test Market Report 2024 - Thyroid Function Test Market Growth A …
"The Business Research Company recently released a comprehensive report on the Global Thyroid Function Test Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. Ready to Dive into Something Exciting? Get Your Free Exclusive
Thyroid Ablation Devices Market
Alarming rise in prevalence of thyroid cancer, advancements in thyroid ablation system, rise in government & private funds for development of healthcare sectors, and increase in number of thyroid nodule cases are expected to notably contribute toward the growth of the global thyroid ablation devices market during the forecast period. Rise in prevalence of thyroid cancer and thyroid nodules, demand for minimally invasive procedures, and technological advancements in ablation devices drive
Thyroid Gland Disorders Treatment Market Increasing incidence of Autoimmune Dise …
The global market for thyroid gland disorders features a consolidated vendor landscape with a handful of companies accounting for a major chunk of the global market, observes Transparency Market Research in a recent report. In 2016, the thyroid gland disorders treatment market was dominated by Merck KGaA and AbbVie, Inc., which collectively accounted for more than half of the market. It has been observed that despite the large pool of
Increasing Incidence of Thyroid Gland Disorders Expected to Propel the Thyroid G …
Thyroid gland is made of thyroid cells that absorb iodine from food and convert it into triiodothyronine (T3) and thyroxine (T4). These hormones are released into the blood stream and play an important role in the regulation of metabolism. Thyroid gland disorders are defined as an abnormal release of thyroid hormones which may demand proper therapeutic agents to correct the disorder condition. This report studies the market in a view